Developer docs
API playgroundTry for free, no card

Search company profiles

NeuroOne

Full company profile

uuid00036p3

Namestring
NeuroOne
Legal namestring
Trivikrama Medical Services Pvt Ltd
Websiteurl
neuroone.in
Company typeenum
Private
Founded yearint
2016
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersTiruchirappalli, India
HQ citystring
Tiruchirappalli
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
neurological care services, neurosurgery hospital, spine surgery, neuro rehabilitation, brain tumor treatment
Industry6 codes
1Neurology & Neurosurgical Specialty Hospitals
CodeHLAFAHADPrimaryYes
2Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s)
CodeHLADAJAHPrimaryNo
3Neurocritical Care
CodeHLAKAIAIPrimaryNo
4General Neurology
CodeHLAKAIAAPrimaryNo
5Neurodiagnostic Centers (EEG/EMG/NCS)
CodeHLAFAKAKPrimaryNo
6Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS)
CodeHSADAIACPrimaryNo
NAICS code4 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals62231
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Specialty (except Psychiatric and Substance Abuse) Hospitals6223
  • Diagnostic Imaging Centers621512
SIC code1 code
  • Services-Health Services8000
Product category
Neurological Hospital Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Patient Services Revenue
TypeOne Time License
Description

Revenue generated from direct patient care including consultations, diagnostic services, surgical procedures, and inpatient/outpatient treatment. Revenue is one-time per episode of care with potential for follow-up consultations.

neuroone.in
2Insurance and TPA Revenue
TypeTransaction Fee
Description

Revenue from cashless hospitalization services through empaneled insurance providers and Third Party Administrators (TPAs). Patient bills are processed through insurance with approved amounts.

neuroone.in
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details1 tier
1Room-based pricing tiers from General Wards to Suite Rooms
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Five types of rooms available: General Wards, Single rooms, Executive rooms, Deluxe Rooms, and Suite Rooms. Pricing varies by room category with deposit amount corresponding to selected room type.

neuroone.in
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

NeuroOne Hospital is an independent neurological centre of excellence in Trichy, Tamil Nadu providing comprehensive brain, spine and nerve care. Services span neurology, neurosurgery, neuro-anaesthesia and neuro-critical care, neuro-radiology, neuro-rehabilitation, pain management, and neuropsychiatry delivered through a multidisciplinary specialist team using advanced diagnostic and surgical technology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • More than 1,000 procedures performed annually
+3 more records
Product overview1 text field

NeuroOne Medical Technologies Corporation is a medical device company offering neural electrode technology and ablation systems. The company provides thin neural electrodes (0.8mm diameter) that integrate medication delivery, therapy, and diagnosis in a single device, along with the FDA-cleared OneRF ablation system for neurological procedures.

Product and service9 records
1Neurology
2Neurosurgery
3Neuro Anaesthesia and Neuro Critical Care
4Neuro Radiology
5Neuro Rehabilitation
6Pain Management
7Neuropsychiatry
8Emergency and Trauma Services
9Cashless Insurance Hospitalization
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1OneRF Distribution Partner (Name undisclosed)
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-08-05
Description

NeuroOne Medical Technologies signed a non-binding term sheet to distribute its FDA-cleared OneRF ablation system through this distribution partner. The partnership was expected to close by the end of Q3 2024 and represents a key commercial distribution channel for the company's ablation technology.

mpo-mag.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Apollo Hospitals
TypeBroad incumbent
Description

India's largest multi-specialty hospital chain with a strong neurosciences program across multiple cities including Chennai. Comparable because it competes for the same neurological and neurosurgical patient pool in Tamil Nadu with far greater scale and capital depth.

2Fortis Healthcare
TypeBroad incumbent
Description

National multi-specialty chain with established neurology and neurosurgery programs. Directly comparable as a competing tertiary neuro care provider with broader geographic reach and stronger insurance empanelment.

3MIOT International
TypeBroad incumbent
Description

Chennai-based specialty hospital with a renowned neurosurgery center. Comparable as a Southern India specialty hospital competing for complex neuro cases from Tamil Nadu's tier-2 referral base.

4Kauvery Hospital
TypeDirect peer
Description

Tamil Nadu-headquartered multi-specialty hospital chain with neurology and neurosurgery services in Trichy and other TN cities. Most directly comparable as a regional hospital chain operating in NeuroOne's home geography.

5Manipal Hospitals
TypeBroad incumbent
Description

Large pan-India hospital chain with established neurosciences programs. Comparable as a multi-specialty competitor with broader reach, capital backing, and insurance/TPA network depth.

6Medanta - The Medicity
TypeBroad incumbent
Description

National super-specialty hospital group with strong neurosciences program. Comparable as a tertiary neuro care competitor with reputation for complex case handling and clinical outcomes.

7Billroth Hospitals
TypeRegional player
Description

Chennai-based multi-specialty hospital with neurology and neurosurgery services. Comparable as a Tamil Nadu-headquartered hospital group competing for neuro referrals from the same catchment region.

8Sri Ramachandra Medical Centre
TypeBroad incumbent
Description

Chennai-based tertiary care and teaching hospital with established neurosurgery department. Comparable as a competing specialty neuro provider in the broader Tamil Nadu catchment.

9Vikram Hospital (Bengaluru)
TypeBroad incumbent
Description

South India multi-specialty hospital with neurosciences program. Comparable as a competing tertiary neuro care provider serving southern Indian tier-2 city populations.

10CARE Hospitals
TypeBroad incumbent
Description

Pan-India multi-specialty hospital chain with established neurology and neurosurgery services. Comparable as a competing tertiary neuro care network with similar insurance/TPA-driven model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers8 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles23 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NeuroOne

Neurological Hospital Servicesneuroone.in

NeuroOne firmographics

Firmographics
Name
NeuroOne
Legal name
Trivikrama Medical Services Pvt Ltd
Website
https://neuroone.in
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

NeuroOne industry classification

Industry
Product category
Neurological Hospital Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Diagnostic Imaging Centers (621512)
SIC
Services-Health Services (8000)
akta.pro primary industry
Neurology & Neurosurgical Specialty Hospitals (HLAFAHAD)
akta.pro secondary industries
Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH), Neurocritical Care (HLAKAIAI), General Neurology (HLAKAIAA), Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)

Keywords

  • Neurological care services
  • Neurosurgery hospital
  • Spine surgery
  • Neuro rehabilitation
  • Brain tumor treatment

Where NeuroOne is headquartered

Location

Headquarters

HQ city
Tiruchirappalli
HQ country
India
HQ region
Asia

Offices1 record

Markets served

NeuroOne business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Patient Services Revenue: Revenue generated from direct patient care including consultations, diagnostic services, surgical procedures, and inpatient/outpatient treatment. Revenue is one-time per episode of care with potential for follow-up consultations.
  2. Insurance and TPA Revenue: Revenue from cashless hospitalization services through empaneled insurance providers and Third Party Administrators (TPAs). Patient bills are processed through insurance with approved amounts.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goRoom-based pricing tiers from General Wards to Suite Rooms

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

NeuroOne product offering

Product offering

Core offering

NeuroOne Hospital is an independent neurological centre of excellence in Trichy, Tamil Nadu providing comprehensive brain, spine and nerve care. Services span neurology, neurosurgery, neuro-anaesthesia and neuro-critical care, neuro-radiology, neuro-rehabilitation, pain management, and neuropsychiatry delivered through a multidisciplinary specialist team using advanced diagnostic and surgical technology.

Product overview

NeuroOne Medical Technologies Corporation is a medical device company offering neural electrode technology and ablation systems. The company provides thin neural electrodes (0.8mm diameter) that integrate medication delivery, therapy, and diagnosis in a single device, along with the FDA-cleared OneRF ablation system for neurological procedures.

Differentiator

Problem solved

Functional benefit

Products and services

  • Neurology
  • Neurosurgery
  • Neuro Anaesthesia and Neuro Critical Care
  • Neuro Radiology
  • Neuro Rehabilitation
  • Pain Management
  • Neuropsychiatry
  • Emergency and Trauma Services
  • Cashless Insurance Hospitalization

Quantifiable outcome

  • More than 1,000 procedures performed annually
  • +3 more outcomes

Companies that use NeuroOne

Customer profile

Named customers8 records

Segments3 records

Ideal customer profiles3 records

NeuroOne technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature11 records

NeuroOne partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • OneRF Distribution Partner (Name undisclosed)coreChannel Partner/ Reseller/ Distributor · 5 August 2024NeuroOne Medical Technologies signed a non-binding term sheet to distribute its FDA-cleared OneRF ablation system through this distribution partner. The partnership was expected to close by the end of Q3 2024 and represents a key commercial distribution channel for the company's ablation technology.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

NeuroOne competitors and assessment

Company assessment

Broad incumbents

  • Apollo Hospitals: India's largest multi-specialty hospital chain with a strong neurosciences program across multiple cities including Chennai. Comparable because it competes for the same neurological and neurosurgical patient pool in Tamil Nadu with far greater scale and capital depth.
  • Fortis Healthcare: National multi-specialty chain with established neurology and neurosurgery programs. Directly comparable as a competing tertiary neuro care provider with broader geographic reach and stronger insurance empanelment.
  • MIOT International: Chennai-based specialty hospital with a renowned neurosurgery center. Comparable as a Southern India specialty hospital competing for complex neuro cases from Tamil Nadu's tier-2 referral base.
  • Manipal Hospitals: Large pan-India hospital chain with established neurosciences programs. Comparable as a multi-specialty competitor with broader reach, capital backing, and insurance/TPA network depth.
  • Medanta - The Medicity: National super-specialty hospital group with strong neurosciences program. Comparable as a tertiary neuro care competitor with reputation for complex case handling and clinical outcomes.
  • Sri Ramachandra Medical Centre: Chennai-based tertiary care and teaching hospital with established neurosurgery department. Comparable as a competing specialty neuro provider in the broader Tamil Nadu catchment.
  • Vikram Hospital (Bengaluru): South India multi-specialty hospital with neurosciences program. Comparable as a competing tertiary neuro care provider serving southern Indian tier-2 city populations.
  • CARE Hospitals: Pan-India multi-specialty hospital chain with established neurology and neurosurgery services. Comparable as a competing tertiary neuro care network with similar insurance/TPA-driven model.

Direct peers

  • Kauvery Hospital: Tamil Nadu-headquartered multi-specialty hospital chain with neurology and neurosurgery services in Trichy and other TN cities. Most directly comparable as a regional hospital chain operating in NeuroOne's home geography.

Regional players

  • Billroth Hospitals: Chennai-based multi-specialty hospital with neurology and neurosurgery services. Comparable as a Tamil Nadu-headquartered hospital group competing for neuro referrals from the same catchment region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

NeuroOne social profiles

Digital presence

NeuroOne compliance and trust

Trust signal

Compliance1 record

NeuroOne financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NeuroOne leadership team

Management profile

Number of profiles

Profiles23 records

NeuroOne funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NeuroOne M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeuroOne

What does NeuroOne do?

NeuroOne Hospital is an independent neurological centre of excellence in Trichy, Tamil Nadu providing comprehensive brain, spine and nerve care. Services span neurology, neurosurgery, neuro-anaesthesia and neuro-critical care, neuro-radiology, neuro-rehabilitation, pain management, and neuropsychiatry delivered through a multidisciplinary specialist team using advanced diagnostic and surgical technology.

Is NeuroOne a public or private company?

NeuroOne is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was NeuroOne founded?

NeuroOne was founded in 2016. It employs 1 to 10 people.

Where is NeuroOne based?

NeuroOne is headquartered in Tiruchirappalli, India, in the Asia region.

How does NeuroOne make money?

Two revenue lines are on record. Patient Services Revenue is the primary driver. The others are insurance and TPA Revenue.

Who are NeuroOne's main competitors?

Broad incumbents on record are Apollo Hospitals, Fortis Healthcare, MIOT International, Manipal Hospitals, Medanta - The Medicity, Sri Ramachandra Medical Centre, Vikram Hospital (Bengaluru) and CARE Hospitals. Kauvery Hospital is listed as a direct peer. Billroth Hospitals is listed as a regional player.

Does NeuroOne have an API?

No public API is recorded for NeuroOne.

What industry is NeuroOne in?

NeuroOne's product category is Neurological Hospital Services. Its primary akta.pro industry code is HLAFAHAD, Neurology & Neurosurgical Specialty Hospitals, with a secondary code of HLADAJAH, Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s). Its NAICS code is 62231 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageNeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NeuroOne Medical Technologies Corporation reported granting an inducement award to a new employee in the form of an option to purchase 10,000 shares of common stock at $3.27 per share, the closing price on June 24, 2026. The option vests over four years with 25% vesting after one year and the remainder in equal quarterly installments thereafter. The disclosure is required under Nasdaq Listing Rule 5635(c)(4), which governs equity grants as employment inducements.The Pharma LetterNeuroOne brings in new CBO to advance neurology ambitionsNeuroOne appointed David Wambeke as chief business officer to lead its drug delivery program. He purchased 1 million shares at $0.6704 each, totaling about $670,000, to support clinical and product development.InsideprecisionmedicinePills, Electrodes, Viruses, and Tregs: Growing Medicine’s ToolboxAt the 2026 J.P. Morgan Healthcare Conference, four biotech companies presented platform technologies spanning oral vaccines, oncolytic viruses, Treg-based immunotherapy, and integrated neural diagnostic-therapeutic devices. Vaxart discussed its oral tablet vaccine platform using a non-replicating adenovirus that survives stomach acid and activates mucosal immunity, while Oncolytics Biotech highlighted pelareorep, an intravenously delivered oncolytic virus for gastrointestinal cancers that evades immune clearance by hitchhiking on immune cells. Coya Therapeutics outlined its approach combining low-dose IL-2 with CTLA-4 to restore immune balance in neurodegeneration, and NeuroOne showcased thin neural electrodes (0.8mm diameter) integrating medication delivery, therapy, and diagnosis in a single device. The article reflects a broader industry shift toward delivery mechanisms and platform efficiency over single-asset drug development.